Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Ascorbic acid derivatives improve drug delivery systems.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Applying pseudoceramide improved skin and hair health.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Human placental extract effectively and safely improves melasma, ulcers, and alopecia areata.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Upadacitinib improved multiple immune-related conditions in one patient.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

The niosomes effectively target hair follicles for acne treatment.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.